Pediatric Interventional Cardiology Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Pediatric Interventional Cardiology market is segmented by Device, Procedure (Catheter-Based Valve Implantation, Congenital heart defect correction, Angioplasty, Coronary thrombectomy) and Geography

Market Snapshot

 Pediatric Interventional Cardiology Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 11.1 %
Pediatric Interventional Cardiology Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The pediatric interventional cardiology market is growing at a significant rate, due to the increasing instances of heart diseases in children and the rising technological advancements in the field. Other factors driving the pediatric interventional cardiology market include increasing awareness among the population, increased preference of minimally invasive procedures over conventional surgeries, and the rising number of congenital disorders. However, stringent regulatory policies, expensive treatments, and therapies are likely to hamper the growth of the pediatric interventional cardiology market.

Scope of the Report

Interventional cardiology is the sub-specialty of cardiology that uses intravascular catheter-based techniques with fluoroscopy, to treat coronary artery, valvular, and congenital cardiac diseases. Pediatric interventional cardiology refers to a process of performing interventional cardiology on infants, children, and adolescents up to 18 years. Various procedures that can be performed under interventional cardiology are angioplasty, valvuloplasty, congenital heart defect correction, and coronary thrombectomy.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Stents is Expected to Hold Significant Share in this Market

There are different types of stents available in the market for the pediatric interventional cardiology procedures. Bare Stent, drug-eluting stent, bio-absorbable stent are few among them. According to a new research study published in Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions (SCAI) conducted by Rady Children’s researchers found coronary stent implantation to be a feasible and safe palliative option for children fifteen months and younger.

A bare stent is used to widen any narrowed coronary artery while performing angioplasty. A bare stent is preferred if the blocked vessel is large and the blockages are small. A bare-metal stent is quite economical and helps in fast vascular healing, with no risk of thrombosis.

Drug-eluting stents are used for stenoticarteries, in order to prevent fibrosis by releasing drugs. Unlike bare stents, these help in suppressing restenosis or relocking of the artery after angioplasty and decrease the chances of repeating the angioplasty.

A bio-absorbable stent is made up of a metal or a polymer that is dissolved or absorbed into the body. It is highly advanced than, both, bare stent and drug-eluting stent. Bio-absorbable stents do not cause permanent metal prosthesis. Thrombosis and restenosis are prevented, as the stent disappears.

Pediatric Interventional Cardiology Market Share

Asia Pacific is the fastest growing region in Pediatric Interventional Cardiology Market

North America region has the largest share in global pediatric interventional cardiology market. This can be attributed to the rising incidences of CHDs, nationwide. As per the Centre for Disease Control (CDC), congenital heart defect (CHD) is the most common type of birth defects, which affects nearly 1%, or about 40,000 births per year. The prevalence of some of the mild CHDs is increasing, while the prevalence of other types has remained stable. At least 15% of all CHDs are associated with genetic conditions. Other prime drivers are rising demand for less invasive procedure for high-risk patients, growing prevalence of mitral regurgitation, severe aortic stenosis disorder, and also factors, such as shorter recovery time, less stay in hospitals, favorable outcomes with transcatheter prosthetic valve implantation, and other technological advancements are likely to boost the growth of the Pediatric Interventional Cardiology Market in North America region.

Pediatric Interventional Cardiology Market Growth

Competitive Landscape

Market players in Global Pediatric Interventional Cardiology Market are focusing on the expansion of their product portfolios by adopting inorganic growth strategies such as acquisitions, mergers and partnerships. Major players in Global Pediatric Interventional Cardiology Market are Abbott, Boston Scientific Corporation, Cardinal Health, Edwards Lifesciences Corporation, GE Healthcare, W. L. Gore & Associates, Medtronic, NuMED Inc., and Siemens AG among others.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased R&D Activities Towards Development of Novel Devices

      2. 4.2.2 Rising Incidences of Congenital Heart Diseases

      3. 4.2.3 Technological Advancements in Pediatric Interventional Cardiology

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of the Procedures

      2. 4.3.2 Reimbursement and Regulatory Issues

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Device Type

      1. 5.1.1 Closure Devices

      2. 5.1.2 Transcatheter Heart Valves

      3. 5.1.3 Atherectomy Devices

      4. 5.1.4 Catheters

      5. 5.1.5 Balloons

      6. 5.1.6 Stents

      7. 5.1.7 Others

    2. 5.2 By Procedure

      1. 5.2.1 Catheter-Based Valve Implantation

      2. 5.2.2 Congenital heart defect correction

      3. 5.2.3 Angioplasty

      4. 5.2.4 Coronary thrombectomy

      5. 5.2.5 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 Cardinal Health

      4. 6.1.4 Edwards Lifesciences Corporation

      5. 6.1.5 GE Healthcare

      6. 6.1.6 W. L. Gore & Associates

      7. 6.1.7 Medtronic

      8. 6.1.8 NuMED Inc.

      9. 6.1.9 Siemens Healthneers

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Pediatric Interventional Cardiology Market market is studied from 2018 - 2026.

The Pediatric Interventional Cardiology Market is growing at a CAGR of 11.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Cardinal Health, Medtronic, NuMED Inc., Abbott Laboratories, GE Healthcare are the major companies operating in Pediatric Interventional Cardiology Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!